Reuters logo
BRIEF-Invivo to amend protocol for INSPIRE study to include additional arm
April 13, 2017 / 12:46 PM / 5 months ago

BRIEF-Invivo to amend protocol for INSPIRE study to include additional arm

April 13 (Reuters) - Invivo Therapeutics Holdings Corp :

* It intends to amend its protocol for inspire study to include an additional arm - SEC filing

* Invivo Therapeutics Holdings Corp says plans to submit amended protocol to United States Food And Drug Administration in Q2 of 2017 - SEC filing

* Invivo Therapeutics Holdings - additional arm is in order to gather baseline and outcome measures on thoracic, complete spinal cord injury patients

* Invivo Therapeutics - estimates that 20 to 40 additional patients will participate in additional arm; arm to have no impact on timeline for inspire study Source text: (bit.ly/2nIgYI9) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below